ES2148248T3 - Peptidos de la lipoproteina (a) y su utilizacion. - Google Patents

Peptidos de la lipoproteina (a) y su utilizacion.

Info

Publication number
ES2148248T3
ES2148248T3 ES94101703T ES94101703T ES2148248T3 ES 2148248 T3 ES2148248 T3 ES 2148248T3 ES 94101703 T ES94101703 T ES 94101703T ES 94101703 T ES94101703 T ES 94101703T ES 2148248 T3 ES2148248 T3 ES 2148248T3
Authority
ES
Spain
Prior art keywords
lipoprotein
peptides
well
standard product
immunogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94101703T
Other languages
English (en)
Inventor
Geoffrey Dr Burns
Wolf-Dieter Dr Engel
Christoph Dr Seidel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4310516A external-priority patent/DE4310516A1/de
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2148248T3 publication Critical patent/ES2148248T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL OBJETIVO DE LA INVENCION SON PEPTIDOS QUE MUESTRAN UNA SECUENCIA PARCIAL DE LIPOPROTEINA (A), ASI COMO SU UTILIZACION PARA LA PURIFICACION CROMATOGRAFICA DE AFINIDAD DE ANTICUERPOS, COMO INMUNOGENOS PARA LA ELABORACION DE ANTICUERPOS ASI COMO PRODUCTOS STANDARD EN UN TEST INMUNOLOGICO O COMO HAPTENO COMPETIDOR EN UN TEST DE AGLUTINACION.
ES94101703T 1993-02-09 1994-02-04 Peptidos de la lipoproteina (a) y su utilizacion. Expired - Lifetime ES2148248T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4304638 1993-02-09
DE4310516A DE4310516A1 (de) 1993-02-09 1993-03-31 Lipoprotein (a)-Peptide und deren Verwendung

Publications (1)

Publication Number Publication Date
ES2148248T3 true ES2148248T3 (es) 2000-10-16

Family

ID=25923128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94101703T Expired - Lifetime ES2148248T3 (es) 1993-02-09 1994-02-04 Peptidos de la lipoproteina (a) y su utilizacion.

Country Status (3)

Country Link
EP (1) EP0614912B1 (es)
AT (1) ATE193021T1 (es)
ES (1) ES2148248T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672028B2 (en) * 1992-08-14 1996-09-19 Shino-Test Corporation Peptides containing respective amino acid sequences selected from among those of lipoprotein(a) and apolipoprotein(a), antibodies respectively recognizing these amino acid sequences, and method of assaying with these antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004144A1 (en) * 1984-12-31 1986-07-17 International Genetic Engineering, Inc. Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
EP0327418B1 (fr) * 1988-01-19 1995-04-12 Institut Pasteur Procédé immunométrique pour le dosage de particules de lipoprotéine, anticorps monoclonaux anti-Lp(a) et application au diagnostic de l'athérosclérose
US4945040A (en) * 1988-02-29 1990-07-31 Arch Development Corporation Immunoassay for lipoprotein(a)
AU9088891A (en) * 1990-11-29 1992-06-25 John E. Carbaugh Diagnostic and therapeutic compositions and methods for lipoprotein(a)

Also Published As

Publication number Publication date
EP0614912B1 (de) 2000-05-17
ATE193021T1 (de) 2000-06-15
EP0614912A1 (de) 1994-09-14

Similar Documents

Publication Publication Date Title
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
ES2165851T3 (es) Proteinas multivalentes que se unen a antigenos.
DE69228701D1 (de) Fragmente von Prion Proteinen.
DE69836630D1 (de) Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DE60231651D1 (de) Proteinreinigungsverfahren
CY1112101T1 (el) Νευροτροφικοι παραγοντες
ES2054688T3 (es) Moleculas hibridas recombinantes de inmunoglobulina y su uso.
ES2161682T3 (es) Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ATE142789T1 (de) Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ES2069902T3 (es) Analisis de variante de analito.
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
ATE182366T1 (de) Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte
ES2184803T3 (es) Procedimiento para la realizacion de un ensayo inmunologico en un sistema multifasico.
ES2170195T3 (es) Peptidos del virus de epstein-barr y anticuerpos contra estos peptidos.
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
CU23164A3 (es) Proteina recombinante de union a aminas vasoactivas
ES2175218T3 (es) Peptidos de enlace3 con la protrombina y la trombina.
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.
ES2082429T3 (es) Metodo de deteccion inmunologico.
ES2185652T3 (es) Oligopeptidos derivados de fragmentos de proteinas c-reactiva.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 614912

Country of ref document: ES